IIT Madras’ Centre for Responsible AI Partners with Roche Diagnostics for AI Research

The collaboration will focus on developing ethical and responsible AI frameworks for digital health solutions and diagnostic services.

The Indian Institute of Technology Madras Centre for Responsible AI (CeRAI) has partnered with Roche Diagnostics International Ltd, Switzerland, to advance research in artificial intelligence (AI) and analytics for in-vitro diagnostics (IVD).

As part of the agreement, Roche has joined CeRAI as a Gold Consortium Member under a Memorandum of Understanding (MoU) signed between the two organizations. The collaboration will focus on developing ethical and responsible AI frameworks for digital health solutions and diagnostic services.

Advancing Ethical AI in Healthcare

CeRAI is a virtual interdisciplinary research center at IIT Madras dedicated to promoting ethical and accountable AI development. It aims to establish standards and policies that enhance transparency and responsibility in AI applications.

Highlighting the importance of responsible AI, Prof. B Ravindran, Head of CeRAI, IIT Madras, stated, “Responsible development and deployment of AI systems requires close interaction between AI scientists and domain experts. Roche recognises this and has an active research program on ethical AI and data management. We look forward to working closely with their program in building more robust and ethical systems for AI in healthcare.”

Roche’s Approach to AI-Driven Diagnostics

Roche, a global leader in in-vitro diagnostics and digital health solutions, aims to leverage AI and analytics to improve diagnostic accuracy and patient outcomes.

Manu Dev, Chapter Lead for IVD Analytics Product Domain at Roche Information Solutions (RIS), commented, “At Roche, we believe in the power of data. It helps healthcare providers and patients make informed decisions. The framework agreement with IIT Madras will enable us to collaborate on important research activities related to Analytics and AI in digital health solutions for in-vitro diagnostics. Sharing knowledge and expertise helps us get closer to a better healthcare system for all.”